BGB-DXP604 Alone and in Combination With BGB-DXP593 in Healthy Participants

NCT04669262 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

25

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: BGB-DXP604
DRUG: BGB-DXP593
DRUG: Placebo
DRUG: Placebo

Sponsor

BeiGene